πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 1,444 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 7875262

Aqueous starch-oil dispersions having improved UV stability and absorbing ability

The United States of America, as represented by the Secretary of Agriculture Β· Granted Tue Jan 25 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 20 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7871985

Compositions and methods for inhibiting expression of factor VII gene

Alnylam Pharmaceuticals, Inc. Β· Granted Tue Jan 18 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 13 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7868160

Compositions and methods for inhibiting expression of anti-apoptotic genes

Alnylam Pharmaceuticals, Inc. Β· Granted Tue Jan 11 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 06 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7846907

Double-stranded RNA (dsRNA) and method of use for inhibiting expression of a fusion gene

Alnylam Pharmaceuticals, Inc. Β· Granted Tue Dec 07 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7837999

Method of increasing muscle mass with IGF-1 fusion polypeptides

REGENERON PHARMACEUTICALS, INC. Β· Granted Tue Nov 23 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 18 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7829693

Compositions and methods for inhibiting expression of a target gene

Alnylam Pharmaceuticals, Inc. Β· Granted Tue Nov 09 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7815916

Cloning and expression of HTLV-III DNA

The United States of America, as represented by the Secretary, Health and Human Services Β· Granted Tue Oct 19 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 14 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7795389

Antagonizing TGF-beta activity with various ectodomains TGF-beta receptors used in combina

The Board of Regents of the University of Texas System Β· Granted Tue Sep 14 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 09 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7771729

Methods of potentiating HIV-1-specific CD8+ immune responses involving the concomitant adm

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Aug 10 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 05 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7772259

1,2,4-Oxadiazole benzoic acid compounds and their use for nonsense suppression and the tre

PTC THERAPEUTICS, INC. Β· Granted Tue Aug 10 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 05 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7771963

Methods for determining efficacy of chemotherapeutic agents

Precision Therapeutics, Inc. Β· Granted Tue Aug 10 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 05 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7763590

Compositions and methods for inhibiting expression of a mutant gene

Alnylam Pharmaceuticals, Inc. Β· Granted Tue Jul 27 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 22 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7759320

Compositions and methods for inhibiting expression of a gene from the Ebola

Alnylam Pharmaceuticals, Inc. Β· Granted Tue Jul 20 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 15 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7754676

Defensin-antigen fusion proteins

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Jul 13 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 08 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7749978

Compositions and methods for inhibiting expression of Huntingtin gene

Alnylam Pharmaceuticals, Inc. Β· Granted Tue Jul 06 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 01 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7745388

Peptides for activation and inhibition of Ξ΄PKC

The United States of America as represented by NIH Division of Extramural Inventions and Technology Resources (DEITR) Β· Granted Tue Jun 29 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 24 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7736652

Antibody fusion proteins: effective adjuvants of protein vaccination

The Regents of the University of California Β· Granted Tue Jun 15 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 10 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7737124

Method for expression of small antiviral RNA molecules with reduced cytotoxicity within a

The Regents of the University of California Β· Granted Tue Jun 15 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 10 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7732207

Method for expression of small antiviral RNA molecules within a cell

The Regents of the University of California Β· Granted Tue Jun 08 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 03 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7732167

Interferon-Ξ±/Ξ² binding fusion proteins and therapeutic uses thereof

REGENERON PHARMACEUTICALS, INC. Β· Granted Tue Jun 08 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 03 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7728120

EML4-ALK fusion gene

CUREGENE K.K. Β· Granted Tue Jun 01 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 27 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7727970

Multiple promoter expression cassettes for simultaneous delivery of RNAi agents targeted t

Benitec, Inc. Β· Granted Tue Jun 01 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 27 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7723474

Molecules that selectively home to vasculature of pre-malignant dysplastic lesions or mali

The Regents of the University of California Β· Granted Tue May 25 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 20 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7723322

Fluoride carrier for positron emission tomography

The Regents of the University of California Β· Granted Tue May 25 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 20 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted